Get started
SIHUAN PHARMAC.GRP HD-,01SIHUAN PHARMAC.GRP HD-,01SIHUAN PHARMAC.GRP HD-,01

SIHUAN PHARMAC.GRP HD-,01

No trades
See on Supercharts
Overview
Financials News Ideas Discussions Seasonals

TEL1 chart


Full chart

TEL1 upcoming earnings

Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—

Key stats


Market capitalization
‪811.03 M‬ EUR
Dividend yield (indicated)
2.88%
Price to earnings Ratio (TTM)
—
Basic EPS (TTM)
−0.0005 EUR
Net income (FY)
‪−6.92 M‬ EUR
Revenue (FY)
‪238.48 M‬ EUR
Shares float
‪4.15 B‬
Beta (1Y)
1.05

About SIHUAN PHARMACEUTICAL HOLD GP LTD


Sector
Health Technology
CEO
Wei Cheng Guo
Headquarters
Beijing
Website
sihuanpharm.com
Founded
2001
FIGI
BBG00189WS11
Sihuan Pharmaceutical Holdings Group Ltd. engages in the research and development, manufacture, and sale of pharmaceutical products. It operates through the following segments: Medical Aesthetic Products, Innovative Medicine and Other Medicine, and Generic Medicine. The Medical Aesthetic Products refers to the filling, shaping, supporting, supplementing, optoelectronic device, body sculpturing, skin care and others to provide non- or minimally invasive medical aesthetics comprehensive solutions. The company was founded by Feng Sheng Che and Wei Cheng Guo in 2001 and is headquartered in Beijing, China.

Financials


Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:—
‪0.00‬

TEL1 news



Seasonals


Displays a symbol's price movements over previous years to identify recurring trends.

Frequently Asked Questions


Depending on the exchange, the stock ticker may vary. For instance, on FWB exchange SIHUAN PHARMAC.GRP HD-,01 stocks are traded under the ticker TEL1.
TEL1 reached its all-time high on Oct 14, 2014 with the price of 0.8000 EUR, and its all-time low was 0.0535 EUR and was reached on Aug 5, 2024. View more price dynamics on TEL1 chart.
See other stocks reaching their highest and lowest prices.
Yes, you can track SIHUAN PHARMAC.GRP HD-,01 financials in yearly and quarterly reports right on TradingView.
SIHUAN PHARMAC.GRP HD-,01 is going to release the next earnings report on Apr 1, 2025. Keep track of upcoming events with our Earnings Calendar.
TEL1 net income for the last half-year is ‪−4.33 M‬ EUR, while the previous report showed ‪−548.00 K‬ EUR of net income which accounts for −690.00% change. Track more SIHUAN PHARMAC.GRP HD-,01 financial stats to get the full picture.
As of Nov 10, 2024, the company has ‪2.87 K‬ employees. See our rating of the largest employees — is SIHUAN PHARMAC.GRP HD-,01 on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. SIHUAN PHARMAC.GRP HD-,01 EBITDA is ‪−5.05 M‬ EUR, and current EBITDA margin is 1.27%. See more stats in SIHUAN PHARMAC.GRP HD-,01 financial statements.
Like other stocks, TEL1 shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade SIHUAN PHARMAC.GRP HD-,01 stock right from TradingView charts — choose your broker and connect to your account.